Mental Health DailyResearch. Evidence. Perspective.Published research on gaba.
A 2026 medRxiv preprint did not find one simple autism excitation-inhibition signature. Bertelsen et al. found 2 EEG-derived E:I neurosubtypes in 286 autistic males: a 47% inhibition-dominan…
Read articleZuranolone, a novel antidepressant, shows promise in treating depression, as evidenced by a recent meta-analysis. A new study investigated zuranolone’s efficacy and safety, focusing on short…
Read articleAllopregnanolone agonists represent a promising new class of medications for treating depressive disorders. Evidence suggests that allopregnanolone agonists exhibit rapid-onset of antidepres…
Read articleXanax (alprazolam) is a drug of the benzodiazepine class originally developed by Upjohn, a Michigan-based pharmaceutical company (now a subsidiary of Pfizer). In the United States, Xanax fir…
Read articleGabapentin is rumored to have been synthesized by chemists in the 1970s in attempt to develop an antispasmodic agent. After its synthesis, rights to gabapentin were acquired by Parke-Davis (…
Read articleBaclofen is a drug that was originally synthesized in the early 1960s by Heinrich Keberle, a Swiss chemist employed by the pharmaceutical company Ciba-Geigy. At the time of its synthesis, Ke…
Read articleValerian (Valeriana officinalis) is a perennial plant named after the Latin term “valere,” which roughly translates to “strong and healthy.” The plant is considered native to Europe and vari…
Read article
